购物车
您的购物车当前为空
别名 巴拉莫德, MKI-833, MKI833, MKI 833
Balamapimod(又称 MKI-822)是一种小分子 Ras/Raf/MEK 抑制剂,可直接靶向异常激活的 MAPK 信号级联反应,用于抑制与肿瘤转化、炎症信号及病理性细胞增殖相关的异常蛋白激酶活性。通过通路水平的抑制作用,Balamapimod 在卒中、骨质疏松、类风湿性关节炎、多囊肾病、结肠息肉及其他炎症驱动型疾病中显示出明确的研究和治疗相关性。

Balamapimod(又称 MKI-822)是一种小分子 Ras/Raf/MEK 抑制剂,可直接靶向异常激活的 MAPK 信号级联反应,用于抑制与肿瘤转化、炎症信号及病理性细胞增殖相关的异常蛋白激酶活性。通过通路水平的抑制作用,Balamapimod 在卒中、骨质疏松、类风湿性关节炎、多囊肾病、结肠息肉及其他炎症驱动型疾病中显示出明确的研究和治疗相关性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
| 产品描述 | Balamapimod, also known as MKI-822, is a small-molecule Ras/Raf/MEK inhibitor that directly targets deregulated MAPK signaling cascades and is being actively explored to suppress aberrant protein kinase activity implicated in oncogenic transformation, inflammatory signaling, and pathological cell proliferation, with demonstrated therapeutic relevance for stroke, osteoporosis, rheumatoid arthritis, polycystic kidney disease, colonic polyps, and other inflammation-driven disorders through pathway-level inhibition. |
| 别名 | 巴拉莫德, MKI-833, MKI833, MKI 833 |
| 分子量 | 574.14 |
| 分子式 | C30H32ClN7OS |
| CAS No. | 863029-99-6 |
| Smiles | N#CC1=CN=C2C=C(C(OC)=CC2=C1NC3=CC=C(SC4=NC=CN4C)C(Cl)=C3)N5CCC(N6CCCC6)CC5 |
| 密度 | no data available |
| 存储 | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 10 mg/mL (17.42 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多